Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Viral Vector Market to reach USD 7.41 billion by the end of 2030

Global Viral Vector Market Size study & Forecast, by Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), by Application (Cell & Gene Therapy, Vaccine, Biopharmaceutical & Pharmaceutical Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, CROs & CMOs) and Regional Analysis, 2023-2030

Product Code: HLSB-62074575
Publish Date: 27-06-2023
Page: 200

Global Viral Vector Market is valued at approximately USD 3.10 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.5% over the forecast period 2023-2030. A viral vector is a type of tool commonly used in molecular biology and genetic engineering to introduce genetic material into cells. It is constructed using a modified virus that has been rendered harmless for human or animal use and retains the ability to infect cells and deliver its genetic cargo. The Viral Vector Market is expanding because of factors such as increasing demand for gene therapies and rising investments in research and development with immense funding support.

The demand for viral vectors is predicted to increase as genetic abnormalities and infectious diseases become more common. For instance, according to data from the Joint United Nations Programme on HIV/AIDS (UNAIDS), around 38.4 million people had HIV in 2021, and by the end of the year, 28.7 million of those individuals had received antiretroviral therapy. Thus, the market is expanding. Furthermore, the amount of gene therapy research has substantially expanded as a result of the broad acceptance of viral vector medicines, many of which are currently undergoing advanced stages of clinical testing. Retroviral, adenoviral, adeno-associated viral, and lentiviral-based vectors are significant contemporary research and clinical trial candidates. For instance, according to the National Centre for Biotechnology Information, 137 adeno-associated viral-based therapies were in various phases of clinical development. Furthermore, most clinical trials were in their initial stages; nevertheless. 7.7% of them had already advanced to phase III. Along with these, in year 2021, the UK government announced that USD 339 million were invested into the life sciences industry. The USD 78 million dedicated to expanding manufacturing services will support cell and gene therapies, medical devices, and commercial scale production investments by various companies. Thus, rising gene therapy clinical trial activities are fostering market growth. In addition, advancements in genome sequencing and an increased amount of research in this area of gene therapy are creating a lucrative growth opportunity for the market. However, complex manufacturing processes, regulatory challenges, and intellectual property issues stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Viral Vector Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and the region’s increasing disease prevalence, and the rising number of clinical trial activities in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising disease prevalence, rising government funding for gene therapeutics development, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government organizations in the market space.

Major market player included in this report are:
Oxford Biomedica
Thermo Fisher Scientific Inc
Batavia Biosciences B.V.
Spark Therapeutics, Inc.
Regenxbio Inc.
uniQURE N.V.
Asklepios BioPharmaceutical, Inc. (AskBio)

Recent Developments in the Market:
Ø In January 2023, Forecyte Bio, a CDMO that deals with cell and gene therapies, built a new GMP facility to speed up the manufacture of viral vectors, cell therapies, and other goods. Additionally, the building would be about 17,000 square feet in size and include separate cleanrooms for each function.

Global Viral Vector Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Vector Type, Application, End User Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Vector Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Vector Type:
Adeno-associated Virus (AAV)

By Application:
Cell & Gene Therapy
Biopharmaceutical & Pharmaceutical Discovery

By End User:
Pharmaceutical & Biotechnology Companies
Academics & Research Institutes

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Viral Vector Market, by Region, 2020-2030 (USD Billion)
1.2.2. Viral Vector Market, by Vector Type, 2020-2030 (USD Billion)
1.2.3. Viral Vector Market, by Application, 2020-2030 (USD Billion)
1.2.4. Viral Vector Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Viral Vector Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Viral Vector Market Dynamics
3.1. Viral Vector Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing demand for gene therapies Rising investments in research and development with immense funding support
3.1.2. Market Challenges Complex manufacturing process. Regulatory challenges and intellectual property issues.
3.1.3. Market Opportunities Advancements in genome sequencing Increased the amount of research in this area of gene therapy.
Chapter 4. Global Viral Vector Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Viral Vector Market, by Vector Type
5.1. Market Snapshot
5.2. Global Viral Vector Market by Vector Type, Performance – Potential Analysis
5.3. Global Viral Vector Market Estimates & Forecasts by Vector Type 2020-2030 (USD Billion)
5.4. Viral Vector Market, Sub Segment Analysis
5.4.1. Adeno-associated Virus (AAV)
5.4.2. Adenovirus
5.4.3. Lentivirus
5.4.4. Retrovirus
5.4.5. Others
Chapter 6. Global Viral Vector Market, by Application
6.1. Market Snapshot
6.2. Global Viral Vector Market by Application, Performance – Potential Analysis
6.3. Global Viral Vector Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Viral Vector Market, Sub Segment Analysis
6.4.1. Cell & Gene Therapy
6.4.2. Vaccine
6.4.3. Biopharmaceutical & Pharmaceutical Discovery
Chapter 7. Global Viral Vector Market, by End User
7.1. Market Snapshot
7.2. Global Viral Vector Market by End User, Performance – Potential Analysis
7.3. Global Viral Vector Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Viral Vector Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Academics & Research Institutes
7.4.3. CROs & CMOs
Chapter 8. Global Viral Vector Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Viral Vector Market, Regional Market Snapshot
8.4. North America Viral Vector Market
8.4.1. U.S. Viral Vector Market Vector Type breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030 End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Viral Vector Market
8.5. Europe Viral Vector Market Snapshot
8.5.1. U.K. Viral Vector Market
8.5.2. Germany Viral Vector Market
8.5.3. France Viral Vector Market
8.5.4. Spain Viral Vector Market
8.5.5. Italy Viral Vector Market
8.5.6. Rest of Europe Viral Vector Market
8.6. Asia-Pacific Viral Vector Market Snapshot
8.6.1. China Viral Vector Market
8.6.2. India Viral Vector Market
8.6.3. Japan Viral Vector Market
8.6.4. Australia Viral Vector Market
8.6.5. South Korea Viral Vector Market
8.6.6. Rest of Asia Pacific Viral Vector Market
8.7. Latin America Viral Vector Market Snapshot
8.7.1. Brazil Viral Vector Market
8.7.2. Mexico Viral Vector Market
8.8. Middle East & Africa Viral Vector Market
8.8.1. Saudi Arabia Viral Vector Market
8.8.2. South Africa Viral Vector Market
8.8.3. Rest of Middle East & Africa Viral Vector Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Oxford Biomedica Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. Lonza
9.3.3. Thermo Fisher Scientific Inc
9.3.4. Batavia Biosciences B.V.
9.3.5. Biogen
9.3.6. Spark Therapeutics, Inc.
9.3.7. Regenxbio Inc.
9.3.8. uniQURE N.V.
9.3.9. Asklepios BioPharmaceutical, Inc. (AskBio)
9.3.10. Sanofi
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now